Titlebook: Cardiovascular Risk Assessment in Primary Prevention; Michael D. Shapiro Book 2022 The Editor(s) (if applicable) and The Author(s), under

consolidate

Meander

Global Approaches to Risk Assessment: The US Guidelinesimproving cardiovascular risk assessment by studying larger and more diverse epidemiological cohorts, leveraging the power of precision medicine, and incorporating measures of social determinants of health into risk prediction algorithms.

吞下

比喻好

装入胶囊

Family History of Premature Atherosclerotic Cardiovascular Diseasere ASCVD can be used for both individual and population risk stratification and should be collected systematically. In this chapter, we begin with a basic overview of the epidemiology and pathophysiology of familial cardiovascular risk. We then outline the clinical recommendations for collecting a f

incubus

Inflammatory Diseases and Risk of Atherosclerotic Cardiovascular Disease: A New Focus on Preventionwidely used in ASCVD prevention, also have anti-inflammatory properties. Recent large-scale clinical trials among secondary prevention populations have shown additional benefits for specific therapeutics that target inflammation for further reduction of cardiovascular events (i.e., canakinumab and c

goodwill

平躺

Debrief

Cardiovascular Risk Assessment in Primary Prevention

preeclampsia

2196-8969 art risk assessment to prevent cardiovascular disease.DiscusThis book is the first comprehensive text dedicated to risk assessment in the primary prevention of atherosclerotic cardiovascular disease. It provides an overview of current evidence regarding approaches to risk assessment, traditional and